15th Annual Highlights of ASCO Recorded Session

This program is designed for physicians, PAs, nurse practitioners, registered nurses, medical staff and pharmacists in Wisconsin and neighboring states wanting to learn about the latest updates in cancer treatment. The conference is designed to review the current clinical updates from the American Society of Clinical Oncology (ASCO) annual meeting.  The conference will educate regarding practice-changing findings presented at ASCO 2022.

Target Audience

This course is intended for physicians, PAs, nurse practitioners, registered nurses, medical staff and pharmacists in Wisconsin and neighboring states wanting to learn about the latest updates in cancer treatment.

Learning Objectives

At the end of this session, learners should be able to:

  1. Review highlights of the advances in clinical and translational research presented at the 2022 ASCO® annual meeting
     
  2. Identify emerging trends and strategies designed to improve the quality of symptom management and survivorship care
     
  3. Evaluate tools and resources in specific areas of cancer management that can be used to achieve effective cancer care delivery and improve the patient experience
Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 2.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 2.50 Attendance
    Attendance Credit
    • 2.50 Approved AMA PRA Category 1 Credit™
Course opens: 
08/16/2022
Course expires: 
07/01/2023
Cost:
$0.00
Rating: 
0

Course Directors

Michael Mullane, MD; Medical Oncologist, Advocate Aurora Health. Medical Director, Hereditary Cancer Prevention and Management Center; Advocate Aurora Health

James Weese, MD, FACS; Vice President, Cancer Service Line and Clinical Adjunct Professor of Surgery UW School of Medicine & Public Health, Aurora Cancer Care; Advocate Aurora Health

Faculty

Toni Choueiri, MD; Director, Lank Center for Genitourinary Oncology Department of Medical Oncology, Dana-Farber Cancer Institute; Co-Leader, Kidney Cancer Program; Dana-Farber/Harvard Cancer Center; Jerome and Nancy Kohlberg Professor of Medicine; Harvard Medical School

Lawrence Einhorn, MD;  Livestrong Foundation Professor of Oncology Distinguished Professor of Medicine, Department of Medicine, Indiana University

Edward James, MD; Gastrointestinal Oncology- Advocate Medical Group/ Lutheran General Hospital; Cancer Liaison Physician, Advocate Aurora Health, Central Chicagoland Lecturer - Rosalind Franklin Univ. School of Medicine and Science, North Chicago, IL

Brad Kahl, MD; Professor, Department of Medicine, Oncology Division Medical Oncology; Director, Lymphoma Program, Washington University

Rubina Qamar, MD Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health

Corey Shamah, MD Medical Director, Hematology / Oncology, Advocate Aurora Health, Wisconsin

Nataliya Uboha, MD, PhD; Faculty Leader for Cancer Therapy Discovery & Development/Phase I Program; Associate Professor, Department of Medicine, Section of Hematology & Oncology University of Wisconsin

Kari Braun Wisinski, MD;  Professor of Medicine; Chief of the Division of Hematology, Medical Oncology and Palliative Care; Co-Lead, Breast Cancer Disease Oriented Team; Associate Director for Clinical Research, Univ. of Wisconsin Carbone Cancer Ctr.

Disclosure

The following faculty speakers and/or planning committee members have disclosed the following:

Faculty Name

Name of Ineligible Companies

Nature of Relationship

Toni Choueiri, MD

AstraZeneca PLC, Bristol Myers Squibb, Eisai Inc. ​
Eli Lilly and Company, EMD Serono Inc., Exelixis Inc., GlaxoSmithKline PLC ​
Merck & Co., Inc., Novartis International AG, Pfizer Inc.​

Committees: Consultancy regarding therapies for Kidney Cancer/GU Cancers​
ASCO/ESMO/NCCN/NCI and other committees 

 Consultancy fees, advisory boards, payments for clinical trials ​(personal and institutional)

Lawrence Einhorn, MD AmgenStock
Brad Kahl, MD

1. Genentech, ADC Therapeutics, Abbvie, AstraZeneca, BeiGene, Pharmacyclics, Celgene/BMS, TG Therapeutics, Hutchmed, MEI, MTEM, Kite, Epizyme, Takeda, Genmab, Incyte, Lilly​

2. Genentech, ADC Therapeutics, Abbvie, AstraZeneca, BeiGene

1. Consulting ​

 

2. Research Funding

Nataliya Uboha, MD

1. Incyte, AstraZeneca, Pfizer, Boston Gene,       ​
    Helsinn, Taiho Inc., QED & Astellas​

2. Ipsen, Taiho & EMD Serono​

3. Natera, Inc & Exact Sciences

1. Ad Board​

2. Research Funding​

3. Long Position Holdings

Kari Braun Wisinski, MD

1. Pfizer ​
2. Novartis​
3. Sanofi​
4. Eisai​
5. AstraZeneca​
6.Carter/Therapeutics​
7. Seattle Genetics​
8. Genentech/Roche​
9.Daiichi

1. Advisory Board, Other Consulting, Researcher ​(grant to intention), Contracted Research
​2. Advisory Board, Researcher (grant to intention), ​Contracted Research​
3. Advisory Board, Contracted Research
​4. Advisory Board​
5. Advisory Board, Contracted Research​6. Researcher (grant to intention)​
7, 8, 9. Contracted Research.

The other planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. All of the relevant financial relationships listed for [this individual/these individuals] have been mitigated.

Accreditation Statement
In support of improving patient care, Advocate Aurora Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Aurora Health designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 2.50 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 2.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 2.50 Attendance
    Attendance Credit
    • 2.50 Approved AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.


Click “Take Course” to register for this program.  


Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.